Summary: Myriad's Precise MRD test is an ultrasensitive second-generation hybrid-capture-based tumor-informed assay that ...

Dr. Brian Czerniecki, of Moffitt Cancer Center, led a CURE Educated Patient® Updates in Metastatic Breast Cancer event, and ...

Researchers from Johns Hopkins University have identified three subtypes of senescent skin cells with distinct shapes, ...

Biomarkers, recommended vaccines, and managing MS in older patients and children are among topics covered in new CMSC MS care ...

The field of precision medicine has revolutionized our understanding and treatment of diseases, particularly in the realm of cardiopulmonary disorders. This ...

Onc.AI, a digital health company developing advanced AI-driven clinical management solutions for oncology, today announced that findings from a recent collaboration with global biopharma company GSK ...

While artificial intelligence (AI) has shown promising potential, much of its use has remained theoretical or retrospective.

Mosaic Therapeutics has secured the latest pieces in its combination medicine strategy by licensing two clinical stage tumor ...

Before the emergence of data from the SUNLIGHT trial, there were only 2 options for therapy in advanced colorectal cancer: ...

Parkinson’s disease (PD) is a progressive neurodegenerative disorder, that severely impacts motor and non-motor functions. Early detection and effective ...

Everest Biolabs, a pioneering life sciences company dedicated to elevating extracellular vesicle (EV) and exosome research, ...

In-licensing transforms Mosaic from a research and platform company to a clinical-stage oncology business Mosaic will develop proprietary, targeted combination products, supported by proprietary ...